Health Stocks Slide as Trump Picks Industry Skeptic Kennedy
- Immunization companies Moderna, Pfizer bear brunt of losses
- Broader sector hit as president-elect takes aim at industry
Robert F. Kennedy Jr. and Donald Trump.
Photographer: Rebecca Noble/Getty Images
This article is for subscribers only.
Health stocks slumped on Friday as Wall Street weighed the impact that prominent vaccine skeptic Robert F. Kennedy Jr. could have on the industry after President-elect Donald Trump nominated him to lead the nation’s health and medical research agencies.
↵